Novel infectious disease therapeutics are focused on at-risk populations now more than ever. Clinical trials are complex; clinical trials during a public health emergency are even more so.

A strategic and proactive plan that accounts for factors like population-inherent risks and standard of care is necessary to succeed. A good clinical trial design can save money and frustration.

In this playbook, you’ll gain insight into what goes into a good plan, including:

• The specific challenges to recruiting and retention in at risk-populations
• How to adapt a clinical trial during an ongoing disease outbreak
• How an experienced research partner can help develop a plan that earns buy-in from regulators, study site administrators, and clinician.

​